Complications
121 - 135 of
206 Results
Sort Results:
Article:
More payers will recognize the value of pharmacists in improving the quality of patient care
November 2013
Article:
Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of gliptins, or DPP-4 inhibitors, for type 2 diabetes
August 2013
Article:
Belviq (bel-VEEK, lorcaserin) will join Qsymia and other weight loss meds in the battle of the bulge
July 2013
Article:
more emphasis on preventing and treating hypoglycemia in patients with type 2 diabetes
June 2013